Wiskott-Aldrich syndrome: genes and variants
Explore variant evidence for Wiskott-Aldrich syndrome across 2 analyzed proteins (WAS, WRN). Linked ClinVar records include 28 pathogenic or likely pathogenic variants, 123 variants of uncertain significance and 26 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Wiskott-Aldrich syndrome
WAS: Actin nucleation-promoting factor WAS
It couples signaling from immune receptors to actin-cytoskeleton remodeling, enabling immune synapse formation, cell migration, and normal platelet production. Loss-of-function variants cause Wiskott-Aldrich syndrome or X-linked thrombocytopenia, while activating variants can cause severe congenital neutropenia.
28 ClinVar pathogenic / likely pathogenic and 146 uncertain variants in WAS have source records linked to Wiskott-Aldrich syndrome. Association strength is not clinical gene validity.
WRN: Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN
It combines DNA helicase and exonuclease activities to maintain replication forks, telomeres, and genome stability. Biallelic loss-of-function variants cause Werner syndrome, an adult-onset progeroid disorder with premature aging, metabolic disease, atherosclerosis, and increased cancer risk.
0 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in WRN have source records linked to Wiskott-Aldrich syndrome. Association strength is not clinical gene validity.
Where Wiskott-Aldrich syndrome variants cluster
- WAS WH1 (positions 39–148): 21 of 28 ClinVar pathogenic / likely pathogenic variants, 3.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Wiskott-Aldrich syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| WAS R86H | 86 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS R86C | 86 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS F128S | 128 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS E133K | 133 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS T45M | 45 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS L270P | 270 | Pathogenic / likely pathogenic (★★) | |
| WAS I290T | 290 | Pathogenic / likely pathogenic (★★) | |
| WAS A56V | 56 | WH1 | Pathogenic / likely pathogenic (★★) |
| WAS D224G | 224 | Pathogenic / likely pathogenic (★★) | |
| WAS E133D | 133 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS R86P | 86 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS G125R | 125 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS G125E | 125 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS F128C | 128 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS F128L | 128 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS A134V | 134 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS F84L | 84 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS S24P | 24 | Pathogenic / likely pathogenic (★) | |
| WAS L35P | 35 | Pathogenic / likely pathogenic (★) | |
| WAS T48P | 48 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS L101P | 101 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS Y107H | 107 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS T111P | 111 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS S272P | 272 | Pathogenic / likely pathogenic (★) | |
| WAS P58T | 58 | WH1 | Pathogenic / likely pathogenic (★) |
| WAS R86L | 86 | WH1 | Pathogenic / likely pathogenic |
| WAS C43Y | 43 | WH1 | Pathogenic / likely pathogenic |
| WAS M1L | 1 | Pathogenic / likely pathogenic |
Which prediction tools work for Wiskott-Aldrich syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- SIFT: 92 out of 100
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Wiskott-Aldrich syndrome
- Ovarian cancer, also linked to WRN
- X-linked severe congenital neutropenia, also linked to WAS
- Werner syndrome, also linked to WRN
Frequently asked questions
Which genes have records linked to Wiskott-Aldrich syndrome?
This view contains 2 analyzed proteins: WAS, WRN. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 28 pathogenic or likely pathogenic variants, 123 variants of uncertain significance and 26 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 226 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center